Bristol-Myers Squibb Company Price Today
Bristol-Myers Squibb Company
BMY
Healthcare
$103.57B
💰
Market Cap
13.2
💸
Price to Earnings
$3.9
🎉
EPS
+77
🌳
ESG
Consensus Recommendations
Hold Consensus
Buy |
6 |
Strong Buy |
4 |
Hold |
20 |
Sell |
1 |
Strong Sell |
0 |
BMY Price Forecast Target
51.1 👉 69.1 +35%
BMY EPS Forecast
3.9 👉 6.5 +69%
Financials
Profit Margin
18 %
Revenue Growth
0.6 %
Dividend
$ 2.4
Held Percent
0.1% - Insiders
79.0% - Institutions
20.9% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $10.1B
-
💰 Blackrock Inc. $8.6B
-
💰 JP Morgan Chase & Company $4.6B
-
💰 State Street Corporation $4.6B
-
💰 Capital International Investors $3.1B
Stock Ideas
Jim Simons Portfolio
Jim Simons, the mastermind behind the Medallion Fund, has achieved such extraordinary returns that he has skyrocketed to the ranks of the world's wealthiest individuals. The secret to his success lies in the fund's implementation of high-frequency t…
Nelson Peltz Portfolio
Nelson Peltz is a renowned investor known for his astute investment strategies and activist approach. With a portfolio spanning diverse industries, Peltz strategically targets underperforming companies, advocating for changes that unlock their full …
Stephen Mandel Portfolio
Stephen Mandel is the founder and portfolio manager of Lone Pine Capital, one of the largest and most successful hedge funds. Employing rigorous fundamental analysis, Mandel searches globally for qualitatively excellent growth companies trading at r…
Elon Musk Portfolio
Enter the visionary world of Elon Musk, a name that needs no introduction in the realms of innovation, entrepreneurship, and technology. With a trailblazing spirit and an unyielding drive, Musk has become a household name, propelling himself to extr…📮FAQ
Some Frequently Asked Questions.
The Bristol-Myers Squibb Company industry is Drug Manufacturers - General
The Bristol-Myers Squibb Company sector is Healthcare
The Bristol-Myers Squibb Company forecasted predicted Price to Earnings PE ratio is 7.8
The Bristol-Myers Squibb Company Price to Earnings PE ratio is 13.2
The Market Capitalization of Bristol-Myers Squibb Company is $103.57B
There are total of 2018068136 float shares with 79.0% held by Institutions and 0.1% held by insiders
The MBristol-Myers Squibb Company forecasted Earnings per Share EPS is $6.5
The Bristol-Myers Squibb Company Earnings per Share EPS is 3.9
The Bristol-Myers Squibb Company company has $0 gross profits with 18 profit margins
The Bristol-Myers Squibb Company Earnings Growth is -0.089% with -0.129% quarterly earnings growth
The Bristol-Myers Squibb Company Revenue is $45006000128 with 0.006 revenue growth
The price target for Bristol-Myers Squibb Company stock is $69.1 for the high target and $37.8 for the low target
The consensus analyst recommendations for Bristol-Myers Squibb Company is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Bristol-Myers Squibb Company is Hold, with the following breakdown:
- Buy: 6
- Strong Buy: 4
- Hold: 20
- Sell: 1
- Strong Sell: 0
The Beta of Bristol-Myers Squibb Company is 0.4
The dividend of Bristol-Myers Squibb Company is $2.4
The dividend yield of Bristol-Myers Squibb Company is 0.047%
The biggest institutional and mutual fund holders of Bristol-Myers Squibb Company stock are
- Vanguard Group Inc
- Blackrock Inc.
- JP Morgan Chase & Company
- State Street Corporation
The Bristol-Myers Squibb Company ESG Score is 77, with the following breakdown:
- E: 1.31
- S: 14.37
- G: 7.07